Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial.

Ebrahimi, Fahim; Giaglis, Stavros; Hahn, Sinuhe; Blum, Claudine A; Baumgartner, Christine; Kutz, Alexander; van Breda, Shane Vontelin; Mueller, Beat; Schuetz, Philipp; Christ-Crain, Mirjam; Hasler, Paul (2018). Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial. European respiratory journal, 51(4) European Respiratory Society 10.1183/13993003.01389-2017

[img] Text
Ebrahimi, Eur Respir J 2018_2.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (484kB) | Request a copy

Neutrophil extracellular traps (NETs) are a hallmark of the immune response in inflammatory diseases. However, the role of NETs in community-acquired pneumonia (CAP) is unknown. This study aims to characterise the impact of NETs on clinical outcomes in pneumonia.This is a secondary analysis of a randomised controlled, multicentre trial. Patients with CAP were randomly assigned to either 50 mg prednisone or placebo for 7 days. The primary end-point was time to clinical stability; main secondary end-points were length of hospital stay and mortality.In total, 310 patients were included in the analysis. Levels of cell-free nucleosomes as surrogate markers of NETosis were significantly increased at admission and declined over 7 days. NETs were significantly associated with reduced hazards of clinical stability and hospital discharge in multivariate adjusted analyses. Moreover, NETs were associated with a 3.8-fold increased adjusted odds ratio of 30-day mortality. Prednisone treatment modified circulatory NET levels and was associated with beneficial outcome.CAP is accompanied by pronounced NET formation. Patients with elevated serum NET markers were at higher risk for clinical instability, prolonged length of hospital stay and 30-day all-cause mortality. NETs represent a novel marker for outcome and a possible target for adjunct treatments of pneumonia.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine

UniBE Contributor:

Baumgartner, Christine

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0903-1936

Publisher:

European Respiratory Society

Language:

English

Submitter:

Tobias Tritschler

Date Deposited:

21 Jan 2019 13:31

Last Modified:

07 Sep 2021 17:17

Publisher DOI:

10.1183/13993003.01389-2017

PubMed ID:

29519921

BORIS DOI:

10.7892/boris.123226

URI:

https://boris.unibe.ch/id/eprint/123226

Actions (login required)

Edit item Edit item
Provide Feedback